NATIONWIDE COMPOUNDING RX

Serial Number 99008662
661

Registration Progress

Application Filed
Jan 17, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action E-Mailed
Due: Sep 28, 2025 78 days

Trademark Image

NATIONWIDE COMPOUNDING RX

Basic Information

Serial Number
99008662
Filing Date
January 17, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
661
Status Date
Jun 30, 2025
Application
Pending
Classes
005 044

Rights Holder

Nationwide Compounding Rx, LLC

16
Address
14000 N. Hayden Rd. Suite 104
Scottsdale, AZ 85260

Ownership History

Nationwide Compounding Rx, LLC

Original Applicant
16
Scottsdale, AZ

Legal Representation

Attorney
Howard I. Sobelman

USPTO Deadlines

Next Deadline
78 days remaining
Non-Final Action E-Mailed
Due Date
September 28, 2025
Extension Available
Until December 28, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

10 events
Date Code Type Description
Jun 30, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 30, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 30, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 28, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 28, 2025 CNRT R NON-FINAL ACTION WRITTEN
Jun 28, 2025 GNRT F NON-FINAL ACTION E-MAILED
Jun 27, 2025 DOCK D ASSIGNED TO EXAMINER
Jun 25, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 25, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 17, 2025 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Hormone replacement therapy preparations; Pain relief medication; Parapharmaceutical products for use in dermatology; Pharmaceutical preparations for use in dermatology
First Use Anywhere: Jun 1, 2017
First Use in Commerce: Jun 1, 2017
Class 044
Consulting services in the field of hormone replacement therapy; Medical clinic providing weight loss solutions, services and programs, nutrition counseling, hormone therapy, including, bioidentical hormone replacement, and natural hormone therapy; Pediatric health care services; Medical services in the field of treatment of chronic pain
First Use Anywhere: Jun 1, 2017
First Use in Commerce: Jun 1, 2017

Additional Information

Design Mark
The mark consists of a pharmacist's mortar and pestle above the words "Nationwide Compounding" bookended on one side by "RX".
Color Claim
Color is not claimed as a feature of the mark.
Other
NATIONWIDE has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in commerce that the U.S. Congress may lawfully regulate for at least the five years immediately before the date of this statement. NATIONWIDE has become distinctive of the goods/services as evidenced by the ownership on the Principal Register for the same mark for sufficiently similar goods/services of active U.S. Registration No(s). 5485233

Classification

International Classes
005 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
COMPOUNDING RX